Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1

被引:181
作者
Yoo, YG
Kong, G
Lee, MO [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, BioMAX Inst, Seoul, South Korea
[3] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea
关键词
HDAC1; HIF-1; alpha; hypoxia; metastasis; MTA1;
D O I
10.1038/sj.emboj.7601025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of metastasis-associated protein 1 (MTA1) correlates well with tumor metastases; however, the associated molecular mechanism is not fully understood. Here, we explored the possibility of cross-talk between MTA1 and hypoxia-inducible factor-1 alpha (HIF-1 alpha), a key regulator of angiogenic factors. We observed that the expression of MTA1 was strongly induced under hypoxia in breast cancer cell lines such as MCF-7 and MDA-MB-231. When MTA1 was overexpressed, the transcriptional activity and stability of HIF-1 alpha protein were enhanced. MTA1 and HIF-1 alpha are physically associated in vivo and they were localized completely in the nucleus when coexpressed. MTA1 induced the deacetylation of HIF-1 alpha by increasing the expression of histone deacetylase 1 (HDAC1). MTA1 counteracted to the action of acetyltransferase, ARD1, and it did not stabilize the HIF-1 alpha mutant that lacks the acetylation site, K532R. These results indicate that acetylation is the major target of MTA1/HDAC1 function. Collectively, our data provide evidence of a positive cross-talk between HIF-1 alpha and MTA1, which is mediated by HDAC1 recruitment, and indicate a close connection between MTA1-associated metastasis and HIF-1-induced tumor angiogenesis.
引用
收藏
页码:1231 / 1241
页数:11
相关论文
共 51 条
[1]   RETRACTED: Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis (Retracted article. See vol. 142, pg. 1388, 2015) [J].
Bagheri-Yarmand, R ;
Talukder, AH ;
Wang, RA ;
Vadlamudi, RK ;
Kumar, R .
DEVELOPMENT, 2004, 131 (14) :3469-3479
[2]   Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF [J].
Bilton, R ;
Mazure, N ;
Trottier, E ;
Hattab, M ;
Déry, MA ;
Richard, DE ;
Pouysségur, J ;
Brahimi-Horn, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) :31132-31140
[3]   Mi-2/NuRD: multiple complexes for many purposes [J].
Bowen, NJ ;
Fujita, N ;
Kajita, M ;
Wade, PA .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2004, 1677 (1-3) :52-57
[4]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[5]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[6]   Cobalt chloride-induced estrogen receptor α down-regulation involves hypoxia-inducible factor-1α in MCF-7 human breast cancer cells [J].
Cho, JY ;
Kim, D ;
Lee, SK ;
Lee, YJ .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (05) :1191-1199
[7]   Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer:: Retrospective study in a series of 745 patients [J].
Dales, JP ;
Garcia, S ;
Meunier-Carpentier, S ;
Andrac-Meyer, L ;
Haddad, O ;
Lavaut, MN ;
Allasia, C ;
Bonnier, P ;
Charpin, C .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) :734-739
[8]   Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma [J].
de Ruijter, AJM ;
Meinsma, RJ ;
Bosma, P ;
Kemp, S ;
Caron, HN ;
van Kuilenburg, ABP .
EXPERIMENTAL CELL RESEARCH, 2005, 309 (02) :451-467
[9]   Genetic basis of human breast cancer metastasis [J].
Debies, MT ;
Welch, DR .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (04) :441-451
[10]   Clinical development of histone deacetylase inhibitors as anticancer agents [J].
Drummond, DC ;
Noble, CO ;
Kirpotin, DB ;
Guo, ZX ;
Scott, GK ;
Benz, CC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :495-528